MF
Magnetar Financial Portfolio holdings
AUM
$20.6B
1-Year Return
277.1%
This Quarter Return
-1.5%
1 Year Return
+277.1%
3 Year Return
+508.13%
5 Year Return
+1,079.47%
10 Year Return
+7,239.49%
AUM
$4.34B
AUM Growth
-$274M
(-5.9%)
Cap. Flow
-$796M
Cap. Flow
% of AUM
-18.33%
Top 10 Holdings %
Top 10 Hldgs %
21.46%
Holding
838
New
327
Increased
113
Reduced
95
Closed
240
Top Buys
| 1 |
Sanofi
SNY
|
$82.2M |
| 2 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$79.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$72.1M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
$71.9M |
| 5 |
Interpublic Group of Companies
IPG
|
$67.4M |
Top Sells
| 1 |
Globus Medical
GMED
|
$100M |
| 2 |
McKesson
MCK
|
$90.2M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$89.6M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
$88.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$82.8M |
Sector Composition
| 1 | Healthcare | 30.12% |
| 2 | Technology | 11.82% |
| 3 | Materials | 7.62% |
| 4 | Financials | 7.33% |
| 5 | Communication Services | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Cannae Holdings
CNNE
$1.09B
| $199K | ﹤0.01% |
+10,010
| New | +$199K |
|
527
Invesco
IVZ
$9.81B
| $199K | ﹤0.01% |
11,363
+28
| +0.2% | +$489 |
|
528
Accel Entertainment
ACEL
$969M
| $196K | ﹤0.01% |
18,385
+3,759
| +26% | +$40.1K |
|
529
Lands' End
LE
$439M
| $195K | ﹤0.01% |
+14,806
| New | +$195K |
|
530
Amicus Therapeutics
FOLD
$2.46B
| $189K | ﹤0.01% |
20,113
-1,964
| -9% | -$18.5K |
|
531
NCR Voyix
VYX
$1.84B
| $189K | ﹤0.01% |
+13,638
| New | +$189K |
|
532
Alight
ALIT
$2B
| $188K | ﹤0.01% |
+27,231
| New | +$188K |
|
533
Semrush
SEMR
$1.15B
| $186K | ﹤0.01% |
15,653
+933
| +6% | +$11.1K |
|
534
Yext
YEXT
$1.1B
| $183K | ﹤0.01% |
28,766
+4,245
| +17% | +$27K |
|
535
Nu Skin
NUS
$569M
| $183K | ﹤0.01% |
+26,510
| New | +$183K |
|
536
Liberty Global Class A
LBTYA
$4.05B
| $179K | ﹤0.01% |
14,056
-14,316
| -50% | -$183K |
|
537
Wendy's
WEN
$1.97B
| $173K | ﹤0.01% |
+10,629
| New | +$173K |
|
538
Enhabit
EHAB
$395M
| $171K | ﹤0.01% |
+21,887
| New | +$171K |
|
539
Leggett & Platt
LEG
$1.35B
| $164K | ﹤0.01% |
+17,126
| New | +$164K |
|
540
Vermilion Energy
VET
$1.12B
| $156K | ﹤0.01% |
+16,632
| New | +$156K |
|
541
nLIGHT
LASR
$1.44B
| $156K | ﹤0.01% |
14,873
-9,809
| -40% | -$103K |
|
542
Bausch Health
BHC
$2.72B
| $151K | ﹤0.01% |
+18,693
| New | +$151K |
|
543
Flushing Financial
FFIC
$457M
| $148K | ﹤0.01% |
10,341
-6,578
| -39% | -$93.9K |
|
544
Adtran
ADTN
$781M
| $140K | ﹤0.01% |
+16,846
| New | +$140K |
|
545
AvidXchange
AVDX
$2.06B
| $137K | ﹤0.01% |
+13,226
| New | +$137K |
|
|
GTM
546
ZoomInfo Technologies
GTM
$3.26B
| $125K | ﹤0.01% |
+11,925
| New | +$125K |
|
547
ADC Therapeutics
ADCT
$398M
| $111K | ﹤0.01% |
55,762
| – | – |
|
548
Iovance Biotherapeutics
IOVA
$901M
| $108K | ﹤0.01% |
+14,623
| New | +$108K |
|
|
NKGN
549
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| $95.5K | ﹤0.01% |
+267,508
| New | +$95.5K |
|
|
BRSP
550
BrightSpire Capital
BRSP
$772M
| $82.8K | ﹤0.01% |
+14,686
| New | +$82.8K |
|